• About
  • Contact
  • Resources
  • Book Nook
Donate
  • Featured
  • Commentary
  • Science & News
  • Mainstream
    • Mainstream Prevention
    • Mainstream Treatment
    • Vaccines
    • Repurposed Drugs
  • Integrative
    • Integrative Prevention
    • Integrative Treatments
    • Integrative Recovery
      • Long Haul
  • Controversies
    • Ivermectin
  • Blog
    • Michael Lerner’s Blog
    • Guest Authors
MenuClose
  • Featured
  • Commentary
  • Science & News
  • Mainstream Solutions
    • Mainstream Prevention
    • Mainstream Treatment
    • Vaccines
    • Repurposed Drugs
  • Integrative Therapies
    • Integrative Prevention
    • Integrative Treatments
    • Integrative Recovery
      • Long Haul
  • Controversies
    • Ivermectin
  • Blog
    • Guest Authors
    • Michael Lerner’s Blog
  • About
  • Contact
  • Resources
  • Donate

USRTK


U.S. Right to Know confirms a third maximum containment lab in China

U.S. Right to Know confirms a third maximum containment lab in China

by Covid Strategies | Apr 26, 2022 | Featured, Science & News

A new maximum biocontainment lab in Kunming, China, was certified three years ago while remaining under-the-radar in the U.S. biodefense community, documents obtained through a Freedom of Information Act request show. China’s plans to build an ABSL-4 under the...

read more
Lab accident is ‘most likely but least probed’ COVID origin, State Dept. memo says

Lab accident is ‘most likely but least probed’ COVID origin, State Dept. memo says

by Covid Strategies | Mar 28, 2022 | Featured, Science & News

State Department officials considered a lab accident to be the most likely cause of COVID-19 in the pandemic’s early months and worried that international virologists may help with a coverup, according to a 2020 memo obtained by U.S. Right to Know. “Origin...

read more

Address:

Commonweal P.O Box 316 | Bolinas, CA 94924

Latest Covid news in your inbox!

Success!

Subscribe

Search Articles

©2021 CovidStrategies/Commonweal | Site maintained by Mercury Multimedia

Privacy Policy | Home